Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? (Q43436806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Tjeerd P van Staa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Frank de Vries

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

6

Peter Vestergaard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

5

Hubert G M Leufkens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1

Marloes T Bazelier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2

Arlene M Gallagher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

6 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

Pharmacoepidemiology and Drug Safety

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

507-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?

25 January 2020

cites work

1 reference

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Skeletal consequences of thiazolidinedione therapy

21 January 2018

1 reference

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

21 January 2018

1 reference

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

21 January 2018

1 reference

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial

21 January 2018

1 reference

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

21 January 2018

1 reference

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

21 January 2018

1 reference

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

21 January 2018

1 reference

A cohort study of thiazolidinediones and fractures in older adults with diabetes

21 January 2018

1 reference

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

21 January 2018

1 reference

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients

21 January 2018

1 reference

Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.

21 January 2018

1 reference

Current use of thiazide diuretics and prevention of femur fractures

21 January 2018

1 reference

Risk of hip/femur fracture after stroke: a population-based case-control study.

21 January 2018

1 reference

Use of statins and risk of fractures

21 January 2018

1 reference

Use of oral corticosteroids and risk of fractures.

21 January 2018

1 reference

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

21 January 2018

1 reference

Use of anti-depressants and the risk of fracture of the hip or femur.

21 January 2018

1 reference

Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006

21 January 2018

1 reference

Skeletal involvement in patients with diabetes mellitus.

21 January 2018

1 reference

Long-term bone loss in insulin-dependent diabetic patients with microvascular complications

21 January 2018

1 reference

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues

21 January 2018

1 reference

Fracture risk with intermittent high-dose oral glucocorticoid therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392882%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference